ログイン

CLINICAL MICROSCOPY PRE-TEST

CLINICAL MICROSCOPY PRE-TEST
33問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    Blood vessel that supply blood to the kidney: a. Renal artery b. Renal vein c. Peritubular capillaries d. None of these

    a. Renal artery

  • 2

    Following collection, urine specimens should be delivered to the laboratory promptly and tested within: a. 30 minutes b. 1 hour c. 2 hours d. 3 hours

    c. 2 hours

  • 3

    In the four-glass urine collection method, which of the following is tested for URETHRAL INFECTION: a. VB1 b. VB2 c.EPS d. VB3

    a. VB1

  • 4

    Individual from whom specimen for drug testing is collected: a. Collector b. Donor c. Patient d. Pusher

    b. Donor

  • 5

    Urine solute exhibiting diurnal variation: a. Creatinine b. Glucose c. Nitrite d. 17-hydroxysteroids

    d. 17-hydroxysteroids

  • 6

    IN 24-HOUR (OR TIMED) SPECIMEN: Many solutes exhibit DIURNAL VARIATIONS such as: In which the lowest concentration is in the early morning and the highest concentration occurs in the afternoon.

    = Catecholamines = 17-hydroxysteroids * Electrolytes

  • 7

    Normal urine odor: a. Cabbage, hops b. Mousy, barny c. Ammoniacal d. Aromatic

    d. Aromatic

  • 8

    Lack of odor in urine from patients with: a. Isovaleric acidemia b. Phenylketonuria c. Acute tubular necrosis d. Pre-renal failure

    c. Acute tubular necrosis

  • 9

    In athletic pseudonephritis, urinalysis result reveals: a. Increased glucose b. Increased ketones c. Increased WBCs d. Increased casts

    d. Increased casts

  • 10

    Collecting duct RTE cells: a. Columnar b. Cuboidal c. Round d. Oval

    b. Cuboidal

  • 11

    Primary urinalysis results: = Leukocyturia = Bacteriuria = Microscopic hematuria = Mild proteinuria = Increased pH a. Acute interstitial nephritis b. Acute pyelonephritis c. Acute tubular necrosis d. Cystitis

    d. Cystitis

  • 12

    Primary urinalysis results: = Leukocyturia * Bacteriuria = WBC casts = Bacterial casts * Microscopic hematuria * Proteinuria a. Acute interstitial nephritis b. Acute pyelonephritis ¢. Acute tubular necrosis d. Cystitis

    b. Acute pyelonephritis

  • 13

    Urinalysis results include hematuria, possibly macroscopic, mild to moderate proteinuria, numerous WBCs, and WBC casts without the presence of bacteria: a. Acute interstitial nephritis b. Acute pyelonephritis c. Acute tubular necrosis d. Cystitis

    a. Acute interstitial nephritis

  • 14

    Urinalysis findings include mild proteinuria, microscopic hematuria, and most noticeably the presence of RTE cells and RTE cell casts containing tubular fragments consisting of three or more cell: a. Acute interstitial nephritis b, Acute pyelonephritis c. Acute tubular necrosis d. Cystitis

    c. Acute tubular necrosis

  • 15

    failure to inherit the gene to produce the enzyme hypoxanthine guanine phosphorlbosyltranslerase is responsible for the accumulation of __ throughout the body. a. Calcium carbonate b. Calcium oxalate c. Cystine d. Uric acid

    d. Uric acid

  • 16

    Urinary crystals associated with foods high In oxalic acid, such as tomatoes and asparagus, and ascorbic acid: a. Ammonium biurate b. Calcium carbonate c. Magnesium ammonium phosphate d. Calcium oxalate

    d. Calcium oxalate

  • 17

    Cholesterol crystals are soluble in: i v a. 10% NaOH b. Ammonia c. Chloroform d. Dilute HCI

    c. Chloroform

  • 18

    Staghorn calculi: ) a. Uric acid b. Weddelite c. Whewellite d. Struvite

    d. Struvite

  • 19

    Cylindroids, but should be considered to be, and enumerated along with: a. Mucus strands b. Oval fat bodies c. RTE cells d. Hyaline casts

    d. Hyaline casts

  • 20

    Biggest variable in urinalysis testing is the conscientiousness of the laboratory personnel in: a. Physical examination of urine b. Microscopic examination ¢. Interpretation of color reactions d. Reporting of result

    ¢. Interpretation of color reactions

  • 21

    Hold the reagent strip ___while comparing it with the color chart is recommended. a. Horizontally b. Vertically c. Either of these d . None of these

    a. Horizontally

  • 22

    Reagent pad for protein: trace values are considered to be: a. Less than 25 mg/dL b. Less than 30 mg/dL c. 100 mg/dL d. 300 mg/dL

    b. Less than 30 mg/dL

  • 23

    Reflectance photometry uses the principle that light reflection from the test pads ___in proportion to the intensity of color produced by the concentration of the test substance. a. Increases b. Decreases c. Variable d. Undetermined

    b. Decreases

  • 24

    As little as 0.1 mL of CSF combined with one drop of ___produces an adequate cell yield when processed with the cytocentrifuge. a. 10% formalin b. 40% formalin c. 10% albumin d. 30% albumin

    d. 30% albumin

  • 25

    A DAILY CONTROL SLIDE FOR BACTERIA in CSF: a. 95% ethanol b. 30% albumin ¢. 0.2 mL saline and 2 drops 95% ethanol d. 0.2 mL saline and 2 drops 30% albumin

    d. 0.2 mL saline and 2 drops 30% albumin

  • 26

    For an accurate evaluation of CSF glucose, a blood glucose test must be run for comparison. The blood glucose should be drawn about ___ the spinal tap to allow time for equilibration between the blood and fluid. a. 2 hours after the spinal tap b. 2 hours before the spinal tap ¢. 8 hours after th.a spinal tap d. 8 hours before the spinal tap

    b. 2 hours before the spinal tap

  • 27

    CSF test is frequently requested for patients with coma of unknown origin: a. Glucose b. Glutamine c. Lactate d. Protein

    b. Glutamine

  • 28

    The test of choice to detect neurosyphilis is the: a. RPR b. VDRL c. MHA-TP d. FTA-ABS

    d. FTA-ABS

  • 29

    ADENOSINE DEAMINASE (ADA) levels of ___ or greater are present in about 99.6% of patients with verified tuberculous pleuritis. a. 4% b. 40% c.4UL d. 40 UL

    d. 40 UL

  • 30

    Black pleural fluid: a. Hemothorax b. Rupture of amoebic liver abscess c. Chylous material from thoracic duct leakage d. Aspergillus infection

    d. Aspergillus infection

  • 31

    By far the most frequently performed fecal analysis is the detection of: a. Carbohydrates b. Fats c. Muscle fibers d. Occult blood

    d. Occult blood

  • 32

    Which of the following urine sediment particles cannot be autovalidated but will be flagged and must be reviewed by laboratory personnel? a. RBCs b. WBCs c. RTEs d. Squamous epithelial cell

    c. RTEs

  • 33

    1Q 200 preclassifies (autoclassified by the analyzer) the following urine particles EXCEPT: a. Nonsquamous epithelial cells b. Bacteria ¢. Unclassified casts d. Uric acid crystals

    d. Uric acid crystals

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    Blood vessel that supply blood to the kidney: a. Renal artery b. Renal vein c. Peritubular capillaries d. None of these

    a. Renal artery

  • 2

    Following collection, urine specimens should be delivered to the laboratory promptly and tested within: a. 30 minutes b. 1 hour c. 2 hours d. 3 hours

    c. 2 hours

  • 3

    In the four-glass urine collection method, which of the following is tested for URETHRAL INFECTION: a. VB1 b. VB2 c.EPS d. VB3

    a. VB1

  • 4

    Individual from whom specimen for drug testing is collected: a. Collector b. Donor c. Patient d. Pusher

    b. Donor

  • 5

    Urine solute exhibiting diurnal variation: a. Creatinine b. Glucose c. Nitrite d. 17-hydroxysteroids

    d. 17-hydroxysteroids

  • 6

    IN 24-HOUR (OR TIMED) SPECIMEN: Many solutes exhibit DIURNAL VARIATIONS such as: In which the lowest concentration is in the early morning and the highest concentration occurs in the afternoon.

    = Catecholamines = 17-hydroxysteroids * Electrolytes

  • 7

    Normal urine odor: a. Cabbage, hops b. Mousy, barny c. Ammoniacal d. Aromatic

    d. Aromatic

  • 8

    Lack of odor in urine from patients with: a. Isovaleric acidemia b. Phenylketonuria c. Acute tubular necrosis d. Pre-renal failure

    c. Acute tubular necrosis

  • 9

    In athletic pseudonephritis, urinalysis result reveals: a. Increased glucose b. Increased ketones c. Increased WBCs d. Increased casts

    d. Increased casts

  • 10

    Collecting duct RTE cells: a. Columnar b. Cuboidal c. Round d. Oval

    b. Cuboidal

  • 11

    Primary urinalysis results: = Leukocyturia = Bacteriuria = Microscopic hematuria = Mild proteinuria = Increased pH a. Acute interstitial nephritis b. Acute pyelonephritis c. Acute tubular necrosis d. Cystitis

    d. Cystitis

  • 12

    Primary urinalysis results: = Leukocyturia * Bacteriuria = WBC casts = Bacterial casts * Microscopic hematuria * Proteinuria a. Acute interstitial nephritis b. Acute pyelonephritis ¢. Acute tubular necrosis d. Cystitis

    b. Acute pyelonephritis

  • 13

    Urinalysis results include hematuria, possibly macroscopic, mild to moderate proteinuria, numerous WBCs, and WBC casts without the presence of bacteria: a. Acute interstitial nephritis b. Acute pyelonephritis c. Acute tubular necrosis d. Cystitis

    a. Acute interstitial nephritis

  • 14

    Urinalysis findings include mild proteinuria, microscopic hematuria, and most noticeably the presence of RTE cells and RTE cell casts containing tubular fragments consisting of three or more cell: a. Acute interstitial nephritis b, Acute pyelonephritis c. Acute tubular necrosis d. Cystitis

    c. Acute tubular necrosis

  • 15

    failure to inherit the gene to produce the enzyme hypoxanthine guanine phosphorlbosyltranslerase is responsible for the accumulation of __ throughout the body. a. Calcium carbonate b. Calcium oxalate c. Cystine d. Uric acid

    d. Uric acid

  • 16

    Urinary crystals associated with foods high In oxalic acid, such as tomatoes and asparagus, and ascorbic acid: a. Ammonium biurate b. Calcium carbonate c. Magnesium ammonium phosphate d. Calcium oxalate

    d. Calcium oxalate

  • 17

    Cholesterol crystals are soluble in: i v a. 10% NaOH b. Ammonia c. Chloroform d. Dilute HCI

    c. Chloroform

  • 18

    Staghorn calculi: ) a. Uric acid b. Weddelite c. Whewellite d. Struvite

    d. Struvite

  • 19

    Cylindroids, but should be considered to be, and enumerated along with: a. Mucus strands b. Oval fat bodies c. RTE cells d. Hyaline casts

    d. Hyaline casts

  • 20

    Biggest variable in urinalysis testing is the conscientiousness of the laboratory personnel in: a. Physical examination of urine b. Microscopic examination ¢. Interpretation of color reactions d. Reporting of result

    ¢. Interpretation of color reactions

  • 21

    Hold the reagent strip ___while comparing it with the color chart is recommended. a. Horizontally b. Vertically c. Either of these d . None of these

    a. Horizontally

  • 22

    Reagent pad for protein: trace values are considered to be: a. Less than 25 mg/dL b. Less than 30 mg/dL c. 100 mg/dL d. 300 mg/dL

    b. Less than 30 mg/dL

  • 23

    Reflectance photometry uses the principle that light reflection from the test pads ___in proportion to the intensity of color produced by the concentration of the test substance. a. Increases b. Decreases c. Variable d. Undetermined

    b. Decreases

  • 24

    As little as 0.1 mL of CSF combined with one drop of ___produces an adequate cell yield when processed with the cytocentrifuge. a. 10% formalin b. 40% formalin c. 10% albumin d. 30% albumin

    d. 30% albumin

  • 25

    A DAILY CONTROL SLIDE FOR BACTERIA in CSF: a. 95% ethanol b. 30% albumin ¢. 0.2 mL saline and 2 drops 95% ethanol d. 0.2 mL saline and 2 drops 30% albumin

    d. 0.2 mL saline and 2 drops 30% albumin

  • 26

    For an accurate evaluation of CSF glucose, a blood glucose test must be run for comparison. The blood glucose should be drawn about ___ the spinal tap to allow time for equilibration between the blood and fluid. a. 2 hours after the spinal tap b. 2 hours before the spinal tap ¢. 8 hours after th.a spinal tap d. 8 hours before the spinal tap

    b. 2 hours before the spinal tap

  • 27

    CSF test is frequently requested for patients with coma of unknown origin: a. Glucose b. Glutamine c. Lactate d. Protein

    b. Glutamine

  • 28

    The test of choice to detect neurosyphilis is the: a. RPR b. VDRL c. MHA-TP d. FTA-ABS

    d. FTA-ABS

  • 29

    ADENOSINE DEAMINASE (ADA) levels of ___ or greater are present in about 99.6% of patients with verified tuberculous pleuritis. a. 4% b. 40% c.4UL d. 40 UL

    d. 40 UL

  • 30

    Black pleural fluid: a. Hemothorax b. Rupture of amoebic liver abscess c. Chylous material from thoracic duct leakage d. Aspergillus infection

    d. Aspergillus infection

  • 31

    By far the most frequently performed fecal analysis is the detection of: a. Carbohydrates b. Fats c. Muscle fibers d. Occult blood

    d. Occult blood

  • 32

    Which of the following urine sediment particles cannot be autovalidated but will be flagged and must be reviewed by laboratory personnel? a. RBCs b. WBCs c. RTEs d. Squamous epithelial cell

    c. RTEs

  • 33

    1Q 200 preclassifies (autoclassified by the analyzer) the following urine particles EXCEPT: a. Nonsquamous epithelial cells b. Bacteria ¢. Unclassified casts d. Uric acid crystals

    d. Uric acid crystals